Strongbridge Biopharma Earlier Reported Q3 EPS $(0.25) Beats $(0.27) Estimate, Sales $5.684M Beat $5.02M Estimate

Strongbridge Biopharma (NASDAQ:SBBP) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.27) by 7.41 percent. This is a 46.81 percent increase over losses of $(0.47) per share

Benzinga · 11/07/2019 14:34

Strongbridge Biopharma (NASDAQ:SBBP) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.27) by 7.41 percent. This is a 46.81 percent increase over losses of $(0.47) per share from the same period last year. The company reported quarterly sales of $5.684 million which beat the analyst consensus estimate of $5.02 million by 13.23 percent. This is a 6.30 percent increase over sales of $5.347 million the same period last year.